2018/2019 ICD-10-CM Diagnosis Code R97.1. Elevated cancer antigen 125 [CA 125] 2016 2017 2018 2019 Billable/Specific Code. R97.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Elevated cancer antigen 125 [CA 125] R97.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM R97.1 became effective on October 1, 2019.
Encounter for antibody response examination Z01.84 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM Z01.84 became effective on October 1, 2020. This is the American ICD-10-CM version of Z01.84 - other ...
The values measured are defined by the use of the monoclonal antibody (MAb) OC 125. The antigenic determinant CA 125 is located on a high-molecular weight glycoprotein (200-1000 kd) isolated from cell culture or serum.
Elevated cancer antigen 125 [CA 125] R97. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R97. 1 became effective on October 1, 2021.
A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in the blood. This test may be used to monitor certain cancers during and after treatment. In some situations, the test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease.
Cancer antigen 125 (CA 125) is the only tumor marker recommended for clinical use in the diagnosis and management of ovarian cancer.
Medicare currently covers the use CA-125 for monitoring of response to therapy related to ovarian cancer. Based on this strong association between these two conditions, we believe that CA-125 testing is reasonable and necessary for monitoring response to therapy for PPC.
The cancer antigen 125 (CA 125) blood test isn't recommended for women with an average risk of ovarian cancer. While women with ovarian cancer often have an elevated level of CA 125 , an elevated CA 125 level doesn't always mean you have ovarian cancer.
How do I interpret my test results for certain types of ovarian cancer? The normal range of a CA 125 is less than 35. If your CA 125 is higher than 35, your doctor will consider your symptoms, the results from your scans (such as CT scan) if you had them done and your clinic examination.
It's typically ordered every two to four months for the first two years following the completion of cancer treatment. After this period, the test is ordered every six months for three years and then once per year. Some doctors may recommend the CA-125 blood test to women with a strong family history of ovarian cancer.
Results: Using a CA125 cutoff of 30 U/mL, an overall sensitivity of 94.8% (96.6% specificity) was obtained when comparing malignancies versus healthy postmenopausal controls, whereas a cutoff of 65 U/mL provided a sensitivity of 83.9% (99.6% specificity).
CA-125 (Rs. 750/-)
LOINC MapOrder CodeOrder Code NameResult Code Name002303Cancer Antigen (CA) 125Cancer Antigen (CA) 125